1.1 Blepharospasm‐specific severity |
3 |
|
Mean Difference (IV, Random, 95% CI) |
0.93 [0.61, 1.25] |
1.2 Blepharospasm‐specific disability |
3 |
290 |
Mean Difference (IV, Random, 95% CI) |
0.69 [0.18, 1.19] |
1.3 Adverse events |
2 |
169 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.18 [0.87, 1.60] |
1.4 Vision complaints (diplopia, blurred vision, visual disturbance) |
2 |
228 |
Risk Ratio (M‐H, Fixed, 95% CI) |
5.73 [1.79, 18.36] |
1.5 Eyelid ptosis |
3 |
289 |
Risk Ratio (M‐H, Fixed, 95% CI) |
4.02 [1.61, 10.00] |
1.6 Increased lacrimation |
2 |
228 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.04 [0.46, 9.13] |
1.7 Xerophthalmia |
2 |
228 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.83 [0.69, 4.86] |
1.8 Frequency of blepharospasm‐specific involuntary movements |
2 |
|
Std. Mean Difference (IV, Random, 95% CI) |
0.79 [0.31, 1.27] |
1.9 Subjective participant evaluation |
2 |
170 |
Std. Mean Difference (IV, Fixed, 95% CI) |
0.86 [0.53, 1.20] |
1.10 Tolerability – dropouts |
2 |
169 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.44 [0.31, 6.79] |